Antidotes for Factor Xa Inhibitors and Methods of Using the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 60/976,343, filed Sep 28, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,455,441 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence UsedRemaining | Alexion Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 8,889,129 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | Alexion Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,062,298 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Low confidence | Alexion Pharmaceuticals, Inc. | In force | Low confidence | ||
| US 9,388,401 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | Alexion Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,587,233 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | Alexion Pharma International Operations Unlimited Company | In force | High confidence | ||
| US 10,190,111 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | Alexion Pharma International Operations Unlimited Company | In force | High confidence | ||
| US 10,675,335 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | Alexion Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 10,954,503 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | Alexion Pharma International Operations Unlimited Company | In force | Medium confidence | ||
| US 11,839,646 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | Alexion Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,109,046 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | Alexion Pharma International Operations Unlimited Company | In force | High confidence | ||
| 4 more records in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
7 of these are in force and held by Alexion Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.